Canada OKs silicone implants
This article was originally published in The Gray Sheet
Allergan and Mentor receive medical device licenses from Health Canada for their silicone gel-filled breast implants Oct. 20. The licenses for Allergan's Inamed round, smooth and textured implants, Inamed Style 410 shaped and textured implants, and Mentor's MemoryGel round and CPG contour implants come with a number of conditions, including that the firms begin long-term studies of tens of thousands of women and conduct focus groups of patients and plastic surgeons related to product labeling, all within one year. As in the U.S., silicone gel-filled breast implants previously were available only on a restricted basis in Canada. Both firms are still awaiting FDA go-ahead for the products after receiving "approvable" letters in 2005 (1"The Gray Sheet" Sept. 26, 2005, p. 17)...
You may also be interested in...
Inamed's silicone gel-filled breast implants inched closer to the market with the receipt of an FDA "approvable" letter, after the firm removed the controversial Style 153 implants from its PMA application
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.